Cargando…
Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data
Drug-related problems (DRPs), i.e., adverse drug reactions (ADRs) and medication errors (MEs), constitute a serious threat to the patient’s safety. DRPs are often insufficiently captured by clinical routine documentation, and thus, they frequently remain unaddressed. The aim of this study was to ass...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821018/ https://www.ncbi.nlm.nih.gov/pubmed/36615115 http://dx.doi.org/10.3390/jcm12010315 |
_version_ | 1784865597860872192 |
---|---|
author | Andrikyan, Wahram Jung-Poppe, Lea Altenbuchner, Anna Nicolaus, Hagen Fabian Pfistermeister, Barbara Dormann, Harald Fromm, Martin F. Maas, Renke |
author_facet | Andrikyan, Wahram Jung-Poppe, Lea Altenbuchner, Anna Nicolaus, Hagen Fabian Pfistermeister, Barbara Dormann, Harald Fromm, Martin F. Maas, Renke |
author_sort | Andrikyan, Wahram |
collection | PubMed |
description | Drug-related problems (DRPs), i.e., adverse drug reactions (ADRs) and medication errors (MEs), constitute a serious threat to the patient’s safety. DRPs are often insufficiently captured by clinical routine documentation, and thus, they frequently remain unaddressed. The aim of this study was to assess the coverage and usability of the new 11th revision of the WHO International Classification of Diseases (ICD-11) to document DRPs. We refined the ‘Quality and Safety Algorithm’ from the ICD-11 Reference Guide and used it for DRP reporting to code 100 different anonymized DRPs (50 ADRs and 50 MEs) in a German hospital. The ICD-11 three-part model consisting of harm, cause, and mode was used whenever they were applicable. Of 50 ADRs, 15 (30.0%), such as drug-induced osteoporosis, were fully classifiable and codable by the ICD-11, whereas 35 (70.0%), such as drug-induced hypokalaemia, could not be fully classified due to sanctioning rules preventing the postcoordination (i.e., a combination of specific codes, such as drug and diagnosis). However, coding without the loss of information was possible in the 35 of these 35 (100.0%) ADR cases when we were deviating from the cluster code order of the Reference Guide. In all 50 MEs, the mode could be encoded, but for none of the MEs, postcoordination, i.e., the assignment of the ME to a specific drug, was allowed. In conclusion, the ICD-11 three-part model enables us to acquire more detailed documentation of DRPs than the previous ICD versions did. However, the codability, documentation, and reporting of DRPs could be significantly improved by simple modifications of the current ICD-11 sanctioning rules and by the addition of new ICD-11 codes. |
format | Online Article Text |
id | pubmed-9821018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98210182023-01-07 Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data Andrikyan, Wahram Jung-Poppe, Lea Altenbuchner, Anna Nicolaus, Hagen Fabian Pfistermeister, Barbara Dormann, Harald Fromm, Martin F. Maas, Renke J Clin Med Article Drug-related problems (DRPs), i.e., adverse drug reactions (ADRs) and medication errors (MEs), constitute a serious threat to the patient’s safety. DRPs are often insufficiently captured by clinical routine documentation, and thus, they frequently remain unaddressed. The aim of this study was to assess the coverage and usability of the new 11th revision of the WHO International Classification of Diseases (ICD-11) to document DRPs. We refined the ‘Quality and Safety Algorithm’ from the ICD-11 Reference Guide and used it for DRP reporting to code 100 different anonymized DRPs (50 ADRs and 50 MEs) in a German hospital. The ICD-11 three-part model consisting of harm, cause, and mode was used whenever they were applicable. Of 50 ADRs, 15 (30.0%), such as drug-induced osteoporosis, were fully classifiable and codable by the ICD-11, whereas 35 (70.0%), such as drug-induced hypokalaemia, could not be fully classified due to sanctioning rules preventing the postcoordination (i.e., a combination of specific codes, such as drug and diagnosis). However, coding without the loss of information was possible in the 35 of these 35 (100.0%) ADR cases when we were deviating from the cluster code order of the Reference Guide. In all 50 MEs, the mode could be encoded, but for none of the MEs, postcoordination, i.e., the assignment of the ME to a specific drug, was allowed. In conclusion, the ICD-11 three-part model enables us to acquire more detailed documentation of DRPs than the previous ICD versions did. However, the codability, documentation, and reporting of DRPs could be significantly improved by simple modifications of the current ICD-11 sanctioning rules and by the addition of new ICD-11 codes. MDPI 2022-12-31 /pmc/articles/PMC9821018/ /pubmed/36615115 http://dx.doi.org/10.3390/jcm12010315 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Andrikyan, Wahram Jung-Poppe, Lea Altenbuchner, Anna Nicolaus, Hagen Fabian Pfistermeister, Barbara Dormann, Harald Fromm, Martin F. Maas, Renke Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data |
title | Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data |
title_full | Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data |
title_fullStr | Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data |
title_full_unstemmed | Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data |
title_short | Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data |
title_sort | documentation of drug-related problems with icd-11: application of the new who code-set to clinical routine data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821018/ https://www.ncbi.nlm.nih.gov/pubmed/36615115 http://dx.doi.org/10.3390/jcm12010315 |
work_keys_str_mv | AT andrikyanwahram documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT jungpoppelea documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT altenbuchneranna documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT nicolaushagenfabian documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT pfistermeisterbarbara documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT dormannharald documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT frommmartinf documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata AT maasrenke documentationofdrugrelatedproblemswithicd11applicationofthenewwhocodesettoclinicalroutinedata |